Literature DB >> 17586333

Baseline psychosocial predictors of survival in localized melanoma.

Ulla-Sisko Lehto1, Markku Ojanen, Tadeusz Dyba, Arpo Aromaa, Pirkko Kellokumpu-Lehtinen.   

Abstract

OBJECTIVE: There is no certainty about the contributing factors or the psychological processes involved in cancer progression. Many studies have suffered from poor theoretical basis, methodological flaws, and only one or few psychosocial factors investigated at a time. We examined the simultaneous contribution of several theory-based psychosocial elements to survival time in melanoma.
METHODS: A consecutive sample of patients with localized (Clarke II-IV) melanoma (N=59) were evaluated with validated questionnaires on coping with cancer, anger expression, perceived social support, noncancer life stresses, and domains of quality of life (QOL) 3-4 months after diagnosis. Cox regression analyses were used to determine the predictors of survival time from the date of diagnosis to the date of death or the last follow-up.
RESULTS: After controlling for age, gender, and Breslow depth for the tumor, the baseline psychological variables related to the cancer-prone Type C response pattern, namely, anger nonexpression (repression), hopelessness, and better single-item self-reported QOL predicted shorter survival. Before hopelessness was added to the model, the amount of depressive symptoms and heavy perceived impact of diagnosis were also predictive. In addition, longer survival was strongly predicted by Cognitive Escape-Avoidance coping, which included items close to the concept of denial/minimizing.
CONCLUSION: Anger nonexpression, hopelessness, and overpositive reporting of QOL--all proposed to include in the Type C response style or reflect emotional nonexpression--seem to comprise a set of factors that reduce survival, whereas denial/minimizing response to the diagnosis as such predicts longer survival.

Entities:  

Mesh:

Year:  2007        PMID: 17586333     DOI: 10.1016/j.jpsychores.2007.01.001

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  18 in total

Review 1.  [Psycho-oncological aspects of malignant melanoma. A systematic review from 1990-2008].

Authors:  M E Beutel; M Blettner; S Fischbeck; C Loquay; A Werner; H Marian
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

2.  The association between hope and mortality in homebound elders.

Authors:  Andrea Q Zhu; Christine Kivork; Linh Vu; Meenakshi Chivukula; Joanna Piechniczek-Buczek; Wei Qiao Qiu; Mkaya Mwamburi
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-10       Impact factor: 3.485

3.  Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study.

Authors:  Rachel Isaksson Vogel; Lori G Strayer; Leah Engelman; Heather H Nelson; Anne H Blaes; Kristin E Anderson; DeAnn Lazovich
Journal:  Qual Life Res       Date:  2017-02-27       Impact factor: 4.147

Review 4.  Assessment of patient-reported outcomes in patients with melanoma.

Authors:  Janice N Cormier; Robert L Askew
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

5.  Depression and cancer mortality: a meta-analysis.

Authors:  M Pinquart; P R Duberstein
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

6.  Noncancer life stresses in newly diagnosed cancer.

Authors:  Ulla-Sisko Lehto; Markku Ojanen; Anna Väkevä; Arpo Aromaa; Pirkko Kellokumpu-Lehtinen
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

Review 7.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

8.  Which symptoms matter? Self-report and observer discrepancies in repressors and high-anxious women with metastatic breast cancer.

Authors:  Janine Giese-Davis; Rie Tamagawa; Maya Yutsis; Suzanne Twirbutt; Karen Piemme; Eric Neri; C Barr Taylor; David Spiegel
Journal:  J Behav Med       Date:  2012-10-20

Review 9.  A systematic review of health-related quality of life in cutaneous melanoma.

Authors:  D Cornish; C Holterhues; L V van de Poll-Franse; J W Coebergh; T Nijsten
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

Review 10.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

Authors:  Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2009-12-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.